Senior Director
Janux Therapeutics
Senior Director
Janux Therapeutics
Clinical-stage biotech developing tumor-activated immunotherapies
Salary Range: 257000 to 275000 (Currency: USD) (Pay period: per-year-salary)
Janux Therapeutics is seeking a Senior Director, Clinical Supply Chain will lead and execute Janux’s clinical supply strategy across Phase 1–3 programs, with a focus on enabling progression into late-stage development. This is a hands-on leadership role responsible for ensuring uninterrupted global supply of investigational medicinal product (IMP) while building scalable processes to support growing clinical program complexity.
This role partners closely with Clinical Operations, CMC, Quality, and Regulatory to align supply planning, manufacturing, and trial execution. The ideal candidate brings deep experience in biologics and global clinical trial supply, including hands-on support of late-stage clinical programs in a fast-paced biopharma environment.
Clinical-stage biotech developing tumor-activated immunotherapies
Janux Therapeutics develops cancer immunotherapies that activate the immune system inside tumors to attack cancer while sparing healthy tissue. Its products are tumor-activated and use a proprietary platform masking technology to reduce toxic side effects and improve efficacy compared with traditional T cell engagers. The company advances drug candidates through clinical trials, aiming for regulatory approval and eventual commercialization, with revenue expected from partnerships, licensing, and the sale of approved therapies. Its lead program JANX007 is being evaluated in a Phase 1 trial (ENGAGER PSMA 01) for metastatic prostate cancer to assess safety and preliminary effectiveness.
Explore more opportunities at Janux Therapeutics